Articles with public access mandates - Heather HampelLearn more
Not available anywhere: 4
Review
NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 2.2019: featured updates to the NCCN guidelines
S Gupta, D Provenzale, X Llor, AL Halverson, W Grady, DC Chung, ...
Journal of the National Comprehensive Cancer Network 17 (9), 1032-1041, 2019
Mandates: US National Institutes of Health
Review
Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer
H Hampel
Journal of the National Comprehensive Cancer Network 8 (5), 597-601, 2010
Mandates: US National Institutes of Health
Review
Mutation Frequencies in Patients With Early-Onset Colorectal Cancer—Reply
R Pearlman, A de la Chapelle, H Hampel
JAMA oncology 3 (11), 1587-1587, 2017
Mandates: Cancer Research UK, UK Medical Research Council, Wellcome Trust
Review
Implementing universal cancer screening programs can help sustain genomic medicine programs
AK Rahm, C Bellcross, D Cragun, D Duquette, H Hampel, B Heald
Personalized Medicine 17 (1), 9-13, 2020
Mandates: US National Institutes of Health
Available somewhere: 128
Review
ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes
S Syngal, RE Brand, JM Church, FM Giardiello, HL Hampel, RW Burt
Official journal of the American College of Gastroenterology| ACG 110 (2 …, 2015
Mandates: US National Institutes of Health
Review
Feasibility of screening for Lynch syndrome among patients with colorectal cancer
H Hampel, WL Frankel, E Martin, M Arnold, K Khanduja, P Kuebler, ...
Journal of Clinical Oncology 26 (35), 5783-5788, 2008
Mandates: US National Institutes of Health
Review
Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer
R Pearlman, WL Frankel, B Swanson, W Zhao, A Yilmaz, K Miller, ...
JAMA oncology 3 (4), 464-471, 2017
Mandates: US National Institutes of Health
Review
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
L Senter, M Clendenning, K Sotamaa, H Hampel, J Green, JD Potter, ...
Gastroenterology 135 (2), 419-428. e1, 2008
Mandates: US National Institutes of Health
Review
American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility
ME Robson, AR Bradbury, B Arun, SM Domchek, JM Ford, HL Hampel, ...
Journal of Clinical Oncology 33 (31), 3660-3667, 2015
Mandates: Susan G. Komen
Review
Identification of Lynch syndrome among patients with colorectal cancer
L Moreira, F Balaguer, N Lindor, A De la Chapelle, H Hampel, ...
Jama 308 (15), 1555-1565, 2012
Mandates: US National Institutes of Health, Government of Spain
Review
Discovery of common and rare genetic risk variants for colorectal cancer
JR Huyghe, SA Bien, TA Harrison, HM Kang, S Chen, SL Schmit, ...
Nature genetics 51 (1), 76-87, 2019
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Review
Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
L Baglietto, NM Lindor, JG Dowty, DM White, A Wagner, ...
Journal of the national cancer institute 102 (3), 193-201, 2010
Mandates: US National Institutes of Health, Cancer Research UK, Chief Scientist Office …
Review
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
N Papadimitriou, N Dimou, KK Tsilidis, B Banbury, RM Martin, SJ Lewis, ...
Nature communications 11 (1), 597, 2020
Mandates: US National Institutes of Health, Cancer Research UK, National Institute for …
Review
Clinical relevance of microsatellite instability in colorectal cancer
A De La Chapelle, H Hampel
Journal of Clinical Oncology 28 (20), 3380-3387, 2010
Mandates: US National Institutes of Health
Review
Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations
S Haraldsdottir, H Hampel, J Tomsic, WL Frankel, R Pearlman, ...
Gastroenterology 147 (6), 1308-1316. e1, 2014
Mandates: US National Institutes of Health
Review
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome
EJ Crosbie, NAJ Ryan, MJ Arends, T Bosse, J Burn, JM Cornes, ...
Genetics in Medicine 21 (10), 2390-2400, 2019
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Review
Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results
LC Beamer, ML Grant, CR Espenschied, KR Blazer, HL Hampel, ...
Journal of Clinical Oncology 30 (10), 1058-1063, 2012
Mandates: US National Institutes of Health
Review
Cancer Risks for PMS2-Associated Lynch Syndrome
SW Ten Broeke, HM van der Klift, CMJ Tops, S Aretz, I Bernstein, ...
Journal of Clinical Oncology 36 (29), 2961-2968, 2018
Mandates: US National Institutes of Health, National Health and Medical Research …
Review
Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state‐of‐the‐science review
JT Lowery, DJ Ahnen, PC Schroy III, H Hampel, N Baxter, CR Boland, ...
Cancer 122 (17), 2633-2645, 2016
Mandates: US National Institutes of Health
Review
Characteristics of early-onset vs late-onset colorectal cancer: a review
R Collaborative, AM Zaborowski, A Abdile, M Adamina, F Aigner, ...
JAMA surgery 156 (9), 865-874, 2021
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Publication and funding information is determined automatically by a computer program